Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
American Heart Association Issues New Guidelines Urging Shift to Plant‑Based Protein
The American Heart Association released its five‑year dietary update on March 31, urging Americans to replace animal protein with plant‑based sources and cut ultra‑processed foods. The move intensifies a clash with the U.S. federal dietary guidelines, which still endorse moderate animal‑protein intake, and signals a new direction for clinicians and food manufacturers.
Texas Children’s Hospital Gets $5 Million Legacy Gift to Expand Pediatric Behavioral Health
Texas Children’s Hospital announced a $5 million estate gift from the late Barbara LeGrange, earmarked for its Behavioral Health Initiative. The donation provides $1 million in immediate support and an endowment to expand pediatric mental‑health services across Greater Houston and Austin, addressing...
CDC Acting Director Delays Release of Study Showing Covid Vaccines Cut Severe Illness by 50%
Acting CDC director Dr. Jay Bhattacharya postponed the March 19 release of a Morbidity and Mortality Weekly Report showing that the 2025‑26 Covid‑19 vaccine reduced severe disease risk by roughly 50% among adults. The delay, justified by methodological concerns, has...
Saturday Report 4/11/26 — When Will the Other Melania Shoe Drop?
The Hartmann Report warns that the Trump administration is moving to make Medicare Advantage the default enrollment for seniors, a shift critics say will increase private profit at taxpayers’ expense. Simultaneously, Iran’s recent closure of the Strait of Hormuz is...
Boston University Test Uses 48‑Gene Panel to Predict Lung Cancer Spread Pre‑Surgery
Researchers at Boston University have validated a 48‑gene signature that predicts vascular invasion in early‑stage lung adenocarcinoma from pre‑operative biopsy samples. The test could give surgeons real‑time risk data, steering patients toward more or less aggressive resections and improving long‑term...
UChicago Medicine President Calls for Back‑to‑Basics Leadership to Harness AI
UChicago Medicine President highlighted that successful AI adoption in health care hinges on fundamental leadership practices. He warned that misinformation and patient‑driven AI use are eroding trust, demanding clearer communication and cultural change across hospitals.
Nanomedicine Advances Offer Targeted Breast Cancer Therapy and Early Detection
Researchers have shown that nanocarrier formulations can increase oral bioavailability by more than 3.5‑fold and double tumor‑inhibition rates in pre‑clinical breast‑cancer models. The advances promise more precise drug delivery, reduced toxicity, and earlier detection, potentially changing standard care for the...
A Healthier Profit
"A Healthier Profit," slated for release by Oxford University Press, examines how commercial activity now drives the majority of preventable disease worldwide. The authors argue that food systems, pollution, and climate change—rooted in profit‑seeking business models—are the primary health threats,...
Iovance Biotherapeutics Seen as Small‑Cap Play for Healthcare Gains
Iovance Biotherapeutics reported $263.5 million in sales for its melanoma therapy Amtagvi, a 61% year‑over‑year increase, and analysts see the small‑cap biotech as a possible route to outsized returns despite steep manufacturing costs and regulatory uncertainty. The stock’s underperformance versus broader...
Gilead Price Target Raised to $175 From $171 at Morgan Stanley
Morgan Stanley raised its price target for Gilead Sciences (GILD) to $175, up from $171, while keeping an Overweight rating. The adjustment reflects updated valuation models that incorporate recent IQVIA market trends and intra‑quarter data ahead of Gilead’s Q1 earnings...
Your Nose Could Detect Alzheimer’s Years Before Symptoms Begin
Researchers at Germany's DZNE and LMU discovered that a declining sense of smell can signal Alzheimer’s disease years before memory loss appears. The study, published in Nature Communications, shows that microglia mistakenly attack nerve fibers linking the olfactory bulb to...
Brockton Hospital Still Dealing with Aftermath of Ransomware Attack
Brockton Hospital is reverting to paper‑based processes for the next two weeks after a ransomware attack crippled its electronic systems. The incident, attributed to the Anubis ransomware‑as‑a‑service group, forced ambulance diversions, cancelled chemotherapy sessions and halted new prescription orders. Federal...
WHO Webinar Highlights One Health Risks of Ultra‑Processed Foods
The World Health Organization convened a virtual webinar during its One Health Summit to examine ultra‑processed foods as a cross‑sectoral threat to human, animal and environmental health. Experts presented evidence on how these industrial products drive noncommunicable diseases, climate strain...
How Physician Financial Autonomy Cures Physician Burnout
Physician burnout is increasingly linked to hidden financial costs rather than clinical stress alone, argues Dr. Tonya Kuhn. She shows that a typical 2% annual fee on a $1 million portfolio can shave $1.22 million off 20‑year growth, illustrating the wealth transfer...
Mouse Study Links Sucralose and Stevia to Metabolic Changes Across Generations
Researchers at Universidad de Chile found that mice given sucralose or stevia exhibited gut‑microbiome shifts and gene‑expression changes that persisted into two subsequent generations, leading to impaired glucose tolerance. The findings raise fresh questions about the long‑term safety of popular...
Clinicians Must Fight Back Against Broken Healthcare System
You spent years in training so you could justify a prescription to someone who has never seen a patient. Bettina Reed has practiced family medicine for 33 years. She watched the system go from a 45-dollar visit with no middleman...
Blackstone and TPG Finalize $6.3 B Hologic Buyout, Appoint Former Baxter CEO Joe Almeida
Blackstone and TPG have closed a $6.3 billion takeover of medical‑device maker Hologic, taking the company private at up to $79 per share. The firms also installed José (Joe) E. Almeida, former Baxter CEO, as Hologic’s new chief executive, signaling a...
Amneal Sets $3.1B 2026 Revenue Target, Leverages GLP‑1 Manufacturing Partnership
Amneal Pharmaceuticals announced a 2026 revenue outlook of $3.05‑$3.10 billion, anchored by a manufacturing partnership with Pfizer for GLP‑1 therapies and a push toward complex injectables. The plan relies on a 20‑30 product launch cadence, margin discipline and a reduced net...
Medtronic Launches AI‑enabled Care Platform in New Jersey After Ghana Success
Medtronic and Virtua Health have rolled out the AI‑powered SPICE platform in Camden, New Jersey, extending a program that lowered systolic blood pressure by an average 15% and reduced diabetes A1c by 1.2% in Ghana. The expansion targets high‑risk patients...
11th Circuit Rules Florida Violated Civil Rights of Disabled Children in State Institutions
The 11th U.S. Circuit Court of Appeals held that Florida’s failure to provide adequate in‑home nursing forced at least 139 severely disabled children into nursing homes and left 1,800 more at risk, violating the Americans with Disabilities Act. The decision...
GLP‑1 Drugs Fuel $1 B+ Industry Surge and Spark Patient‑cost Worries
GLP‑1 medications such as Ozempic, Wegovy and Mounjaro are generating a multi‑billion‑dollar lift for gyms, beauty brands and grocery chains, even as users spend up to $1,000 a month on ancillary costs. Experts warn the drugs also create relationship stress...
Hong Kong's New 2,400‑Bed Kai Tak Hospital Opens October
Hong Kong’s largest public hospital will open to patients in phases from October, with the new 2,400-bed facility in Kai Tak set to take over the services of Queen Elizabeth Hospital and become a healthcare hub for Kowloon.
Trump Calls on Congress to Preserve State Medical Marijuana Protections in 2027 Budget
President Donald Trump has asked Congress to maintain a budget provision that bars the Justice Department from interfering with state‑run medical marijuana programs. The 2027 budget request keeps the protection in place but omits Nebraska, highlighting a lingering partisan split...
More Pharma Dealmaking; FDA’s Proposed Budget; Takeda Ends Partnership; and More
The pharma sector is seeing a wave of dealmaking, with Q1 2026 M&A volume up roughly 15% as companies chase high‑value oncology assets. The FDA released a proposed $5.6 billion budget that would raise review fees by about 8% and modestly...
Type 2 Diabetes in Youth Has Risen 70% Since 2013
New research in the New England Journal of Medicine shows that type 2 diabetes among U.S. youth surged 70% between 2013 and 2024, climbing from 0.73 to 1.24 cases per 1,000. The rise is most pronounced in older adolescents, females, and...
Progesterone in MHT for Protection Against Endometrial Cancer
Recent analysis of menopausal hormone therapy (MHT) highlights a tension between breast‑cancer safety and endometrial risk. Observational data from France’s E3N cohort found that women using oral micronized progesterone for five or more years faced a 2.7‑fold increase in endometrial...
Rovner Recaps Medicaid Cuts’ Impact on Hospitals and Fields Caller Questions on Affordability
Julie Rovner, KFF Health News chief Washington correspondent, recapped the impact of recent Medicaid cuts on American hospitals during WAMU’s 1A interview on April 7. She highlighted how reduced Medicaid reimbursements strain hospital cash flow and could force cuts to uncompensated...
Goodbye Balint, Goodbye Neighbour and Goodbye General Practice ?
The author contends that the traditional general‑practice model—rooted in time‑based observation, simple tools, and communication frameworks from Balint, Neighbour and Pendleton—is being displaced by rapid diagnostic technology and artificial intelligence. Screening programmes, instant imaging and AI‑driven patient research have turned...
20 Future Hungarian HealthTech and MedTech Leaders
Hungary’s health‑tech and med‑tech ecosystem is maturing into a deep‑tech hub, backed by more than €925 million (≈ $1 billion) of venture capital between 2015‑2025. State agencies, university‑owned technology transfer companies and accelerators have built a supportive pipeline that channeled €41.2 million (≈ $44.5 million) in...
How AI Medical Scribe Enhances Patient Care
AI-powered medical scribes are reshaping clinical workflows by automating documentation, cutting physician charting time by up to 50%. The technology translates spoken consultation notes into structured electronic health records, improving data accuracy and reducing manual entry errors. With less paperwork,...
One‑sentence AI Pipeline Transforms Drug Discovery Workflow
What if your next drug discovery pipeline started with one sentence, not 6 months of scripting? In this latest deep dive with @scispace, I saw a shift that feels bigger than incremental AI gains. Upload single-cell data and get clustered cell types,...
20 Future Greek HealthTech and MedTech Leaders
Greece’s health‑tech and med‑tech ecosystem has matured into a $4.2 billion market by 2025, driven by policy frameworks such as the Digital Transformation Bible and the 2024 AI Strategy. Capital inflows surged, with total startup funding exceeding €732 million (about $785 million) and...
From Despair to Alliance: Faith Communities and Public Health as Partners in Reclaiming Society's Moral Compass
Professor Raman Bedi argues that the commercial determinants of health—exemplified by a $28,000‑per‑year price tag for a 95% effective HIV prevention drug and a booming wellness market of unproven products—have eroded shared moral values. He contends that faith communities, with...
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Perioperative Outcomes in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis
Researchers performed a systematic review and meta‑analysis of six retrospective cohort studies covering over 48,000 hip and knee arthroplasty patients to assess the impact of pre‑operative glucagon‑like‑peptide‑1 receptor agonist (GLP‑1 RA) therapy. The analysis found a 20 % reduction in revision...
IVERMECTIN and HERPES - 20 Quick Testimonials
An online blog post titled “Ivermectin and Herpes – 20 Quick Testimonials” compiles twenty personal accounts claiming the antiparasitic drug ivermectin alleviates herpes simplex outbreaks. The piece provides no clinical data, dosage information, or peer‑reviewed evidence to support the claims....
Re: The Power of the Markets: The Scandal that Keeps on Taking
Lenacapavir, a once‑monthly injectable for HIV, is priced at $28,000 per patient annually by Gilead Sciences. In a BMJ rapid response, surgeon Simon Bell argued the price reflects the high cost of drug development and that Gilead is not obligated...
New Yellow Fever Vaccine Matches Safety and Effectiveness of Current Shot
Sanofi's new live‑attenuated yellow fever vaccine, vYF, demonstrated safety and efficacy comparable to the licensed YF‑VAX in a phase 2 trial of 485 healthy adults. Protective antibodies appeared in 99.7% of vYF recipients versus 99.4% for YF‑VAX within 28 days, with...
National Prevalence of Diarrhea and Associated Factors Among Children Under Five in Afghanistan
A 2022‑23 survey of 32,989 Afghan children under five found that 38.2% had experienced diarrhea in the past two weeks. The risk was highest for children aged 6‑35 months, while maternal age over 20, higher household wealth, and maternal education...
Britain's Shadow Workforce Is Paid as Little as 65p an Hour. Who Cares for the Carers? | Frances Ryan
Britain’s unpaid care sector now supports almost 6 million people, with 1.9 million providing full‑time care in England—a 70% rise over two decades. Family‑provided services are valued at over £184 bn ($234 bn) a year, eclipsing three‑quarters of NHS spending. Yet the state’s carer’s...
David McWilliams: Is Ireland the Worst Run Country in Europe?
Economist David McWilliams argues that Ireland is Europe’s most mismanaged economy, pointing to unchecked spending and weak cost control. He highlights the national children’s hospital, originally budgeted at €650 million (≈$715 million), which ballooned to €2.24 billion (≈$2.46 billion) by 2025 – a 220%...
New Research Leads to Increased Understanding of Longevity Gains in the United States
A new BMJ Open study by University of Wisconsin–Madison scholars finds that every U.S. state experienced life‑expectancy gains for cohorts born between 1941 and 2000, overturning earlier research that suggested stagnation or declines in parts of the South. Using the...
Health Care Is the Largest Industry in the US by Total Spending and Employment
U.S. health care spending reached $5.3 trillion in 2024, making it the nation’s largest industry by both total outlays and employment. The growth is driven primarily by increased utilization of medical services rather than price inflation, with per‑capita spending climbing to...
EV-RNAs Show Promise for IBD Diagnosis and Treatment
A review in *ExRNA* led by Professor Xiyang Wei outlines how extracellular vesicle‑associated RNAs (EV‑RNAs) influence inflammatory bowel disease (IBD) pathogenesis and progression. By synthesizing multi‑omics and animal data, the authors show EV‑RNAs can serve as highly accurate, non‑invasive biomarkers...
Insilico Medicine Launches Pharma AI Spring Kickoff 2026 Webinar
Insilico Medicine announced the Pharma.AI Spring Kickoff 2026 webinar for April 14, 2026, at 10:00 AM ET. The event will showcase the company’s latest AI-driven drug discovery tools, including the MMAI Gym training framework, upgraded PandaOmics with single‑cell integration, and new capabilities in...
Big Pharma Is Turning to China for the Newest Drug Ideas
Pfizer is intensifying its search for breakthrough cancer treatments by tapping Chinese biotech. Last summer the company paid $1.25 billion to Shanghai‑based 3SBio for rights to a promising oncology candidate. The move reflects a broader shift as China evolves from a...
Safety-Net Dentistry Restores Dignity for Recovering Addicts
Safety-net dentistry restores human dignity for patients recovering from severe addiction [PODCAST] http://dlvr.it/TRzS6T Podcast #PrimaryCare
Government Claims 21% Health Insurance Cost Decline Over Five Years
The most absurd number in CPI? According to the US Government, the cost of health insurance has declined 21% over the last 5 years... https://t.co/l5IYmkeySJ https://t.co/YUTqN8BlGp
Nanomedicine Offers Targeted Solutions for Breast Cancer Treatment
Nanomedicine is reshaping breast cancer therapy by using nanoscale carriers to improve drug solubility, targeting, and controlled release. Recent preclinical studies show lipid‑polymer hybrids boosting oral bioavailability over threefold and photothermal nanoparticles halving tumor growth when combined with chemotherapy. Metallic...
China's Biotech Surge Threatens Western Drug Dominance
Big Pharma Is Turning to China for the Newest Drug Ideas—China’s biotechs are faster and have lower costs, and its drug research threatens to soon overtake the West’s @Loftus https://t.co/YszgDfNlwc https://t.co/YszgDfNlwc
IL6R Protects, IL6 Harms: Genetic Proof of Survival Impact
Causal effects of inflammation on long-term mortality: A mendelian randomization study 🔑"The IL6/IL6R axis has a causal impact on human survival through cardiovascular mechanisms: IL6R exerts a protective effect, whereas IL6 is detrimental." https://t.co/0TwQldDrQe